OpenLB
Open Library of Bioscience
Advanced Search
Frontiers in public health
2023;11 1295464.

Influenza vaccination rates among healthcare workers: a systematic review and meta-analysis investigating influencing factors.

Jingchun Fan, Shijie Xu, Yijun Liu, Xiaoting Ma, Juan Cao, Chunling Fan, Shisan Bao
Author Information
  1. Jingchun Fan: Center for Laboratory and Simulation Training, School of Public Health, Centre for Evidence-Based Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
  2. Shijie Xu: School of Public Health, Gansu University of Chinese Medicine, Lanzhou, China.
  3. Yijun Liu: Social and Historical Sciences, University College London, London, United Kingdom.
  4. Xiaoting Ma: School of Nursing, Gansu University of Chinese Medicine, Lanzhou, China.
  5. Juan Cao: Department of Public Health, Affiliated Hospital of Gansu University of Chinese Medicine, Lanzhou, China.
  6. Chunling Fan: Department of Pharmacy, Gansu Provincial Cancer Hospital, Gansu Provincial Academic Institute for Medical Research, Lanzhou, China.
  7. Shisan Bao: Center for Laboratory and Simulation Training, School of Public Health, Centre for Evidence-Based Medicine, Gansu University of Chinese Medicine, Lanzhou, China.
PMID: 38026311 DOI: 10.3389/fpubh.2023.1295464

Abstract

Introduction: Healthcare workers risk of exposure to the influenza virus in their work, is a high-risk group for flu infections. Thus WHO recommends prioritizing flu vaccination for them-an approach adopted by >40 countries and/or regions worldwide.
Methods: Cross-sectional studies on influenza vaccination rates among healthcare workers were collected from PubMed, EMBASE, CNKI, and CBM databases from inception to February 26, 2023. Influenza vaccination rates and relevant data for multiple logistic regression analysis, such as odds ratios (OR) and 95% confidence intervals (CI), were extracted.
Results: A total of 92 studies comprising 125 vaccination data points from 26 countries were included in the analysis. The meta-analysis revealed that the overall vaccination rate among healthcare workers was 41.7%. Further analysis indicated that the vaccination rate was 46.9% or 35.6% in low income or high income countries. Vaccination rates in the Americas, the Middle East, Oceania, Europe, Asia, and Africa were 67.1, 51.3, 48.7, 42.5, 28.5, and 6.5%, respectively. Influencing factors were age, length of service, education, department, occupation, awareness of the risk of influenza, and/or vaccines.
Conclusion: The global influenza vaccination rate among healthcare workers is low, and comprehensive measures are needed to promote influenza vaccination among this population.
Systematic review registration: www.inplysy.com, identifier: 202350051.

Keywords

healthcare workers influencing factors influenza vaccine meta-analysis vaccination rate

References

  1. Int J Infect Dis. 2018 Oct;75:8-10 [PMID: 30010054]
  2. BMC Public Health. 2017 Sep 5;17(1):692 [PMID: 28870202]
  3. Vaccine. 2017 May 19;35(22):2930-2936 [PMID: 28438409]
  4. Vaccine. 2010 Jul 5;28(30):4751-7 [PMID: 20471438]
  5. MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):993-9 [PMID: 26389743]
  6. Vaccines (Basel). 2022 Mar 18;10(3): [PMID: 35335106]
  7. Influenza Other Respir Viruses. 2018 May;12(3):319-325 [PMID: 29430860]
  8. PLoS One. 2011;6(10):e26239 [PMID: 22028840]
  9. Hum Vaccin. 2007 Jan-Feb;3(1):33-6 [PMID: 17264683]
  10. MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1050-1054 [PMID: 30260944]
  11. Isr Med Assoc J. 2010 Jun;12(6):338-41 [PMID: 20928986]
  12. J Am Med Dir Assoc. 2012 Jan;13(1):85.e17-23 [PMID: 22208764]
  13. Public Health. 2018 Jan;154:102-109 [PMID: 29220709]
  14. Hum Vaccin Immunother. 2022 Nov 30;18(6):2102354 [PMID: 35920744]
  15. MMWR Morb Mortal Wkly Rep. 2014 Sep 19;63(37):805-11 [PMID: 25233281]
  16. Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Nov 6;56(11):1571-1575 [PMID: 36372746]
  17. BMC Health Serv Res. 2018 Nov 14;18(1):853 [PMID: 30428886]
  18. J Prev Med Hyg. 2022 Oct 27;63(3):E405-E414 [PMID: 36415296]
  19. J Prev Med Hyg. 2019 Sep 30;60(3):E178-E183 [PMID: 31650051]
  20. J Hosp Infect. 2017 Jul;96(3):268-275 [PMID: 28283372]
  21. MMWR Morb Mortal Wkly Rep. 2012 Sep 28;61:753-7 [PMID: 23013720]
  22. Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Oct 6;53(10):1018-1021 [PMID: 31607048]
  23. J Infect Dev Ctries. 2010 Oct 28;4(10):636-44 [PMID: 21045356]
  24. Occup Med (Lond). 2015 Dec;65(9):739-45 [PMID: 26276758]
  25. Vaccines (Basel). 2022 May 18;10(5): [PMID: 35632553]
  26. Vaccines (Basel). 2019 Dec 26;8(1): [PMID: 31887994]
  27. J Infect Public Health. 2014 Feb;7(1):70-2 [PMID: 24284023]
  28. Cochrane Database Syst Rev. 2018 Feb 01;2:CD001269 [PMID: 29388196]
  29. Vaccine. 2011 Jun 6;29(25):4190-4 [PMID: 21497636]
  30. Vaccines (Basel). 2022 Aug 18;10(8): [PMID: 36016229]
  31. MMWR Morb Mortal Wkly Rep. 2016 Sep 30;65(38):1026-31 [PMID: 27684642]
  32. Vaccines (Basel). 2019 Sep 29;7(4): [PMID: 31569475]
  33. Vaccine. 2009 Jun 24;27(31):4240-3 [PMID: 19481314]
  34. Med J Malaysia. 2016 Oct;71(5):231-237 [PMID: 28064287]
  35. Int J Environ Res Public Health. 2017 Jul 11;14(7): [PMID: 28696401]
  36. Hum Vaccin Immunother. 2013 Apr;9(4):911-6 [PMID: 24064543]
  37. Am J Infect Control. 2019 Feb;47(2):133-138 [PMID: 30293741]
  38. BMC Public Health. 2008 Dec 23;8:422 [PMID: 19105838]
  39. Eur J Public Health. 2013 Feb;23(1):92-7 [PMID: 22366387]
  40. Vaccine. 2022 Mar 15;40(12):1775-1782 [PMID: 35168841]
  41. Ann Med. 2021 Dec;53(1):384-390 [PMID: 33616423]
  42. Hum Vaccin Immunother. 2021 Jul 3;17(7):2185-2189 [PMID: 33497309]
  43. Hum Vaccin Immunother. 2014;10(5):1204-10 [PMID: 24603089]
  44. Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Nov 6;56(11):1565-1570 [PMID: 36372745]
  45. Vaccines (Basel). 2022 Mar 17;10(3): [PMID: 35335092]
  46. J Prev Med Hyg. 2021 Jul 30;62(2):E377-E381 [PMID: 34604576]
  47. Vaccine. 2015 Jul 31;33(32):3821-8 [PMID: 26144904]
  48. Int J Risk Saf Med. 2011;23(4):249-54 [PMID: 22156090]
  49. Vaccine. 2010 Jun 11;28(26):4283-7 [PMID: 20441803]
  50. J Infect Dev Ctries. 2021 Jul 31;15(7):1004-1013 [PMID: 34343126]
  51. Influenza Other Respir Viruses. 2022 May;16(3):376-385 [PMID: 35122389]
  52. Vaccine. 2012 Jan 20;30(5):911-5 [PMID: 22154772]
  53. Hum Vaccin Immunother. 2014;10(8):2378-86 [PMID: 25424945]
  54. Med Lav. 2020 Oct 15;111(6):449-456 [PMID: 33311420]
  55. PLoS One. 2013 Nov 18;8(11):e81200 [PMID: 24260560]
  56. Infect Dis Poverty. 2022 Oct 8;11(1):105 [PMID: 36209258]
  57. Lancet Respir Med. 2019 Jan;7(1):69-89 [PMID: 30553848]
  58. MMWR Morb Mortal Wkly Rep. 2011 Aug 19;60(32):1073-7 [PMID: 21849963]
  59. Vaccine. 2018 May 31;36(23):3351-3358 [PMID: 29716777]
  60. Vaccines (Basel). 2018 Jan 05;6(1): [PMID: 29303959]
  61. Hum Vaccin Immunother. 2022 Dec 31;18(1):1978795 [PMID: 34613881]
  62. Aust N Z J Public Health. 2002 Feb;26(1):65-8 [PMID: 11895030]
  63. Int J Environ Res Public Health. 2022 Jan 30;19(3): [PMID: 35162609]
  64. Prev Med. 2013 Sep;57(3):206-11 [PMID: 23732251]
  65. Am J Prev Med. 2010 Jul;39(1):74-7 [PMID: 20537842]
  66. Vaccine. 2011 Oct 19;29(45):8113-7 [PMID: 21856362]
  67. MMWR Morb Mortal Wkly Rep. 2017 Sep 29;66(38):1009-1015 [PMID: 28957042]
  68. Influenza Other Respir Viruses. 2021 Nov;15(6):778-788 [PMID: 34114740]
  69. Vaccine. 2018 Jan 25;36(4):535-544 [PMID: 29241645]
  70. Hum Vaccin Immunother. 2016 Sep;12(9):2459-63 [PMID: 27029897]
  71. Int J Nurs Stud. 2018 Mar;79:137-144 [PMID: 29248825]
  72. Am J Infect Control. 2011 Aug;39(6):488-94 [PMID: 21288599]
  73. GMS Infect Dis. 2018 Feb 23;6:Doc02 [PMID: 30671333]

MeSH Term

Humans
Influenza, Human
Cross-Sectional Studies
Influenza Vaccines
Vaccination
Health Personnel

Chemicals

Influenza Vaccines
Meta-Analysis Systematic Review Research Support, Non-U.S. Gov't
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0vaccinationinfluenzaworkersamonghealthcareratesratecountriesanalysismeta-analysisfactorsriskfluand/orstudies26Influenzadatalowincome5reviewinfluencingIntroduction:Healthcareexposurevirusworkhigh-riskgroupinfectionsThusWHOrecommendsprioritizingthem-anapproachadopted>40regionsworldwideMethods:Cross-sectionalcollectedPubMedEMBASECNKICBMdatabasesinceptionFebruary2023relevantmultiplelogisticregressionoddsratiosOR95%confidenceintervalsCIextractedResults:total92comprising125pointsincludedrevealedoverall417%indicated469%356%highVaccinationAmericasMiddleEastOceaniaEuropeAsiaAfrica671513487422865%respectivelyInfluencingagelengthserviceeducationdepartmentoccupationawarenessvaccinesConclusion:globalcomprehensivemeasuresneededpromotepopulationSystematicregistration:wwwinplysycomidentifier:202350051workers:systematicinvestigatingvaccine

Similar Articles

Cited By